Contact
searchSearch
HMP Global
Login

Major Depressive Disorder Excellence Forum

Major Depressive Disorder
Excellence Forum

An illustrated picture shows two cartoon doctors, one holding up a magnifying glass to a cartoon brain.
Conference Coverage
Flexible Dosing of Esketamine Nasal Spray Effective Over Long-Term
11/12/2024
Analysis of a long-term extension study of flexibly dosed esketamine nasal spray, in combination with an oral antidepressant, found durable long-term efficacy and safety of the treatment whether dosed weekly, every other week, or every 4...
Analysis of a long-term extension study of flexibly dosed esketamine nasal spray, in combination with an oral antidepressant, found durable long-term efficacy and safety of the treatment whether dosed weekly, every other week, or every 4...
Analysis of a long-term...
11/12/2024
Psychiatry & Behavioral Health
Sandhya Prashad, MD
Q&As
Unlocking the Power of Ketamine With Sandhya Prashad, MD
05/30/2024

Featuring Sandhya Prashad, MD

Featuring Sandhya Prashad, MD
Sandhya Prashad, MD, discusses ketamine applications for treatment-resistant depression.
Sandhya Prashad, MD, discusses ketamine applications for treatment-resistant depression.
Sandhya Prashad, MD, discusses...
05/30/2024
Psych Congress Network
Jennifer S. De La Rosa, PhD
Q&As
Chronic Pain Cannot be Ignored in Depression and Anxiety
03/22/2024

Featuring Jennifer S. De La Rosa, PhD

Featuring Jennifer S. De La Rosa, PhD...
Jennifer S. De La Rosa, PhD, discusses findings from a groundbreaking study on comorbid depression and/or anxiety and chronic pain.
Jennifer S. De La Rosa, PhD, discusses findings from a groundbreaking study on comorbid depression and/or anxiety and chronic pain.
Jennifer S. De La Rosa, PhD,...
03/22/2024
Psych Congress Network
Rakesh Jain, MD, MPH.
Videos
Approaching Psychedelics for Depression With Both Caution and Optimism
02/06/2024
Rakesh Jain, MD, MPH, explains when clinicians may need to be more cautious when weighing the benefits of psychedelic therapy for depression.
Rakesh Jain, MD, MPH, explains when clinicians may need to be more cautious when weighing the benefits of psychedelic therapy for depression.
Rakesh Jain, MD, MPH, explains...
02/06/2024
Psych Congress Network
Rakesh Jain at Psych Congress Regionals
News
Novel Depression Treatments Focus of Psych Congress Regionals Q&A Session
01/04/2024
Drs Jain and Mattingly answered audience questions regarding GABA and glutamate modulation in understanding and treating the psychological impact of TBI in the frontal lobe, and newer, flexible depression treatment options.
Drs Jain and Mattingly answered audience questions regarding GABA and glutamate modulation in understanding and treating the psychological impact of TBI in the frontal lobe, and newer, flexible depression treatment options.
Drs Jain and Mattingly answered...
01/04/2024
Psych Congress Network
Dr Vlad Maletic
Videos
Beyond Neurotransmitters: Unraveling the Brain Circuitry of Mental Health
11/27/2023
Vladimir Maletic, MD, explores the complexities of brain circuitry and the neurobiological basis of major psychiatric conditions.
Vladimir Maletic, MD, explores the complexities of brain circuitry and the neurobiological basis of major psychiatric conditions.
Vladimir Maletic, MD, explores...
11/27/2023
Psychiatry & Behavioral Health
Dr Ramawamy Viswanathan
Videos
Unlocking the Unique Aspects of Seasonal Affective Disorder for Better Patient Support This Winter
11/21/2023
President-Elect of the APA, Ramaswamy Viswanathan, MD, DrMedSc shares what clinicians need to know about Seasonal Affective Disorder (SAD), and how to better support patients experiencing symptoms.
President-Elect of the APA, Ramaswamy Viswanathan, MD, DrMedSc shares what clinicians need to know about Seasonal Affective Disorder (SAD), and how to better support patients experiencing symptoms.
President-Elect of the APA,...
11/21/2023
Psych Congress Network
Craig Chepke, MD, DFAPA.
Videos
Refining Your Treatment Options for Major Depressive Disorder (MDD)
08/16/2023
Craig Chepke, MD, DFAPA, gives an overview of the 4 antipsychotic adjunctive treatments approved for major depressive disorder.
Craig Chepke, MD, DFAPA, gives an overview of the 4 antipsychotic adjunctive treatments approved for major depressive disorder.
Craig Chepke, MD, DFAPA, gives...
08/16/2023
Psych Congress Network
How does shared decision making impact MDD treatment?
Quiz
How does shared decision making impact MDD treatment?
08/15/2023
Do you remember this Q&A with Nurse Sharp?
Do you remember this Q&A with Nurse Sharp?
Do you remember this Q&A with...
08/15/2023
Psych Congress Network
Greg Mattingly, MD
Videos
Treating Residual MDD Symptoms With Novel Mechanisms
08/08/2023
Greg Mattingly, MD, discusses new mechanisms on the horizon for MDD
Greg Mattingly, MD, discusses new mechanisms on the horizon for MDD
Greg Mattingly, MD, discusses...
08/08/2023
Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Sign Up

Psych Congress Network Newsletter

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use